HST vs KNSA · P/E 16, rev $6.11B vs P/E 53, rev $677.6M
Host Hotels & Resorts Inc (HST) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HST revenue for 2025-12-31 was $6.11B. Net income was $765.0M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
HST currently screens at market cap $15.94B and trailing P/E 15.6. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the HST and KNSA stock pages for the full models.
Not investment advice.